November 2017: Plaintiffs filed an amended complaint similarly alleging that Infants’ Tylenol is marketed as “specially formulated for babies” when, according to the complaint, it is the same as the Children’s Tylenol.
October 2017: A class-action lawsuit was filed against Johnson & Johnson Consumer Inc. for allegedly deceptively representing that Children’s Tylenol and Infants’ Tylenol are different products in order to get consumers to pay more for Infants’ Tylenol when, according to plaintiffs, the medicines contain the same ingredients and the same dosages. (Elkies et al v. Johnson & Johnson Services, Inc. and Johnson & Johnson Consumer Inc., Case No. 17-cv-7320, C. D. CA.)
For more of TINA.org’s coverage of the marketing of Tylenol products, click here.